Published in

American Society of Hematology, Blood, 25(122), p. 4107-4110, 2013

DOI: 10.1182/blood-2013-04-496851

Links

Tools

Export citation

Search in Google Scholar

Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Platelet-von Willebrand factor (VWF) is stored within α-granules and accounts for ~20% of total VWF in platelet-rich plasma. This platelet-VWF pool exists distinct from plasma-VWF and is enriched in high molecular weight multimers (HMWM). Previous studies have described significant functional discrepancies between platelet-VWF and plasma-VWF. However the molecular basis responsible for these differences is not well understood. To address this, we have characterized terminal glycan expression on platelet-VWF. Our findings demonstrate that platelet-VWF exists as a distinct natural glycoform. In particular, N-linked sialylation is markedly reduced (>50%) compared to plasma-VWF. Moreover, unlike plasma-VWF, platelet-VWF does not express AB blood group determinants, although precursor H antigen expression is similar to that observed on plasma-VWF. Importantly, as a result of this differential glycosylation, platelet-VWF exhibits specific resistance to ADAMTS13 proteolysis. Thus platelet activation at sites of vascular injury results in the release of high local concentrations of HMWM platelet-VWF that is more resistant to ADAMTS13, thereby facilitating platelet-plug formation.